Roberta L. McKee

1.3k total citations
24 papers, 1.0k citations indexed

About

Roberta L. McKee is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Roberta L. McKee has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Roberta L. McKee's work include Bone health and treatments (13 papers), Chemical Synthesis and Analysis (9 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Roberta L. McKee is often cited by papers focused on Bone health and treatments (13 papers), Chemical Synthesis and Analysis (9 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Roberta L. McKee collaborates with scholars based in United States, Israel and Australia. Roberta L. McKee's co-authors include Michael P. Caulfield, Michael Rosenblatt, Mark E. Goldman, Jay J. Levy, Ruth F. Nutt, John Fisher, Jane E. Reagan, Michael Chorev, Thomas L. Clemens and Noboru Horiuchi and has published in prestigious journals such as Science, Biochemistry and Endocrinology.

In The Last Decade

Roberta L. McKee

24 papers receiving 964 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta L. McKee United States 14 691 525 113 100 80 24 1.0k
J T Potts United States 8 749 1.1× 388 0.7× 127 1.1× 172 1.7× 45 0.6× 12 1.0k
Frank Barletta United States 17 381 0.6× 466 0.9× 130 1.2× 68 0.7× 44 0.6× 18 1.1k
Valerie A. Ruff United States 16 835 1.2× 336 0.6× 41 0.4× 43 0.4× 305 3.8× 21 1.2k
Thomas K. Barthel United States 9 356 0.5× 73 0.1× 40 0.4× 129 1.3× 50 0.6× 11 669
Janna C. Collins United States 12 566 0.8× 104 0.2× 23 0.2× 74 0.7× 23 0.3× 24 867
Eli Moallem Israel 12 461 0.7× 321 0.6× 22 0.2× 176 1.8× 20 0.3× 13 768
Dony Maiguel United States 12 514 0.7× 80 0.2× 45 0.4× 107 1.1× 20 0.3× 16 981
Robert Huryk United States 14 313 0.5× 100 0.2× 34 0.3× 6 0.1× 24 0.3× 18 806
Krishnendu Roy United States 13 762 1.1× 133 0.3× 17 0.2× 11 0.1× 12 0.1× 24 1.1k
Raymond A. Bendele United States 12 504 0.7× 205 0.4× 183 1.6× 6 0.1× 80 1.0× 15 1.0k

Countries citing papers authored by Roberta L. McKee

Since Specialization
Citations

This map shows the geographic impact of Roberta L. McKee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta L. McKee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta L. McKee more than expected).

Fields of papers citing papers by Roberta L. McKee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta L. McKee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta L. McKee. The network helps show where Roberta L. McKee may publish in the future.

Co-authorship network of co-authors of Roberta L. McKee

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta L. McKee. A scholar is included among the top collaborators of Roberta L. McKee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta L. McKee. Roberta L. McKee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katz, Michael, Gloria E. Gutierrez, Gregory R. Mundy, et al.. (1992). Tumor necrosis factor and interleukin 1 inhibit parathyroid hormone‐responsive adenylate cyclase in clonal osteoblast‐like cell by down‐regulating parathyroid hormone receptors. Journal of Cellular Physiology. 153(1). 206–213. 29 indexed citations
2.
Orloff, John J., et al.. (1992). A pharmacological comparison of parathyroid hormone receptors in human bone and kidney.. Endocrinology. 131(4). 1603–1611. 22 indexed citations
3.
Chorev, Michael, Michael P. Caulfield, Roberta L. McKee, et al.. (1992). A novel, mild, specific and indirect maleimido-based radioiodolabeling method. Radiolabeling of analogs derived from parathyroid hormone (PTH) and PTH-related protein (PTHrP).. PubMed. 40(5). 445–55. 6 indexed citations
5.
6.
Chorev, Michael, Roberta L. McKee, Jane E. Reagan, et al.. (1991). Biological activity of parathyroid hormone antagonists substituted at position 13. Peptides. 12(1). 57–62. 13 indexed citations
7.
McKee, Roberta L., John Fisher, Jay J. Levy, et al.. (1991). Solid-phase synthesis and biologic activity of human parathyroid hormone(1–84). Journal of Bone and Mineral Research. 6(8). 781–789. 6 indexed citations
8.
Caulfield, Michael P., Roberta L. McKee, Mark E. Goldman, et al.. (1990). Parathyroid hormone-related protein (PTHrP): Studies with synthetic peptides indicate that parathyroid hormone and PTHrP interact with the same receptor. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 17(7). 633–637. 3 indexed citations
9.
Chorev, Michael, Mark E. Goldman, Roberta L. McKee, et al.. (1990). Effects of hydrophobic substitutions at position 18 on the potency of parathyroid hormone antagonists. International journal of peptide & protein research. 36(5). 465–470. 11 indexed citations
11.
Chorev, Michael, Mark E. Goldman, Roberta L. McKee, et al.. (1990). Modifications of position 12 in a parathyroid hormone and parathyroid hormone-related protein: toward the design of highly potent antagonists. Biochemistry. 29(6). 1580–1586. 54 indexed citations
13.
McKee, Roberta L., Michael P. Caulfield, & Michael Rosenblatt. (1990). Treatment of Bone-Derived ROS 17/2.8 Cells with Dexamethasone and Pertussis Toxin Enables Detection of Partial Agonist Activity for Parathyroid Hormone Antagonists. Endocrinology. 127(1). 76–82. 24 indexed citations
14.
McKee, Roberta L., Victor J. Hruby, Dev Trivedi, et al.. (1988). Perifused precision-cut liver slice system for the study of hormone-regulated hepatic glucose metabolism. Journal of Pharmacological Methods. 19(4). 339–354. 12 indexed citations
15.
Caulfield, Michael P., Jay J. Levy, Roberta L. McKee, et al.. (1988). AVIAN (CHICKEN) PARATHYROID HORMONE: SYNTHESIS AND COMPARATIVE BIOLOGICAL EVALUATION OF THE 1-34 FRAGMENT. Endocrinology. 123(6). 2949–2951. 11 indexed citations
16.
Rosenblatt, Michael, Michael P. Caulfield, John Fisher, et al.. (1988). A Tumor‐Secreted Protein Associated with Human Hypercalcemia of Malignancy. Annals of the New York Academy of Sciences. 548(1). 137–145. 3 indexed citations
17.
McKee, Roberta L., Mark E. Goldman, Michael P. Caulfield, et al.. (1988). THE 7–34-FRAGMENT OF HUMAN HYPERCALCEMIA FACTOR IS A PARTIAL AGONIST/ANTAGONIST FOR PARATHYROID HORMONESTIMULATED CAMP PRODUCTION. Endocrinology. 122(6). 3008–3010. 56 indexed citations
18.
Goldman, Mark E., Roberta L. McKee, Michael P. Caulfield, et al.. (1988). A NEW HIGHLY POTENT PARATHYROID HORMONE ANTAGONIST: [D-TRPl2,TYR34]bPTH-(7–34)NH2. Endocrinology. 123(5). 2597–2599. 49 indexed citations
19.
Horiuchi, Noboru, Michael P. Caulfield, John Fisher, et al.. (1987). Similarity of Synthetic Peptide from Human Tumor to Parathyroid Hormone in Vivo and in Vitro. Science. 238(4833). 1566–1568. 290 indexed citations
20.
Hruby, Victor J., et al.. (1986). Conformational considerations in the design of glucagon agonists and antagonists: examination using synthetic analogs.. PubMed. 25 Suppl. S135–55. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026